https://www.selleckchem.com/pr....oducts/20-hydroxyecd
Sacral neuromodulation was effective in only 7 patients (6 MPI and 1 AMS). Rather, the profile of the patient in whom NMS is effective is female, mature, and with PID. The long-term effectiveness of NMS is disappointing. Only 2 permanently implanted patients retained urinary benefit. NMS improves urinary symptoms in the patients with Parkinson's disease in 32% of cases. It fluctuates over time and loses its effectiveness in the long term. Recommendations for the treatment of stress urinary incontinence (SUI) due to intrinsic
Like
Comment
Share
